This inventor holds 1 USPTO granted patent. Top assignee: Resprotect Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Martin Fuhrer: Innovator in Uracil Derivatives
Introduction
Martin Fuhrer is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his work on uracil derivatives. His innovative approach has led to advancements in therapeutic agents that are crucial for cancer treatment.
Latest Patents
Martin Fuhrer holds a patent for "Uracil derivatives and use thereof." This patent discloses uracil derivatives of a specific formula, wherein R, R, R, and X are defined within the document. The primary application of these derivatives is as therapeutic agents, particularly in conjunction with cytostatic agents to suppress or reduce resistance that may develop during cytostatic treatment. He has 1 patent to his name.
Career Highlights
Fuhrer is associated with Resprotect GmbH, a company that focuses on developing innovative solutions in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of uracil derivatives in medical treatments.
Collaborations
Some of his notable coworkers include Matthias Klemm and Rudolf Fahrig. Their collaborative efforts contribute to the ongoing research and development in the field of medicinal chemistry.
Conclusion
Martin Fuhrer is a distinguished inventor whose work on uracil derivatives has the potential to significantly impact cancer treatment. His contributions to the field exemplify the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile